Solvay SA

OTCPK:SVYS.F Stock Report

Market Cap: US$3.4b

Solvay Valuation

Is SVYS.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SVYS.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SVYS.F ($32.5) is trading below our estimate of fair value ($55.45)

Significantly Below Fair Value: SVYS.F is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SVYS.F?

Key metric: As SVYS.F is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for SVYS.F. This is calculated by dividing SVYS.F's market cap by their current revenue.
What is SVYS.F's PS Ratio?
PS Ratio0.6x
Sales€5.22b
Market Cap€3.25b

Price to Sales Ratio vs Peers

How does SVYS.F's PS Ratio compare to its peers?

The above table shows the PS ratio for SVYS.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.9x
HUN Huntsman
0.6x5.5%US$3.4b
CC Chemours
0.6x4.8%US$3.3b
LXU LSB Industries
1.2x5.7%US$640.3m
SMG Scotts Miracle-Gro
1.2x2.3%US$4.6b
SVYS.F Solvay
0.6x0.2%US$3.2b

Price-To-Sales vs Peers: SVYS.F is good value based on its Price-To-Sales Ratio (0.6x) compared to the peer average (0.9x).

Price to Sales Ratio vs Industry

How does SVYS.F's PS Ratio compare vs other companies in the US Chemicals Industry?

12 CompaniesPrice / SalesEstimated GrowthMarket Cap
TSE Trinseo
0.04x5.0%US$134.17m
ALTO Alto Ingredients
0.1x3.1%US$107.31m
ENFY Enlightify
0.3xn/aUS$27.07m
BON Bon Natural Life
0.3xn/aUS$6.71m
SVYS.F 0.6xIndustry Avg. 1.4xNo. of Companies15PS01.22.43.64.86+
12 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: SVYS.F is good value based on its Price-To-Sales Ratio (0.6x) compared to the US Chemicals industry average (1.4x).

Price to Sales Ratio vs Fair Ratio

What is SVYS.F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SVYS.F PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.6x
Fair PS Ratio1.9x

Price-To-Sales vs Fair Ratio: SVYS.F is good value based on its Price-To-Sales Ratio (0.6x) compared to the estimated Fair Price-To-Sales Ratio (1.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SVYS.F forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$32.50
US$34.77
+7.0%
12.9%US$41.91US$27.24n/a16
Nov ’25US$41.50
US$35.22
-15.1%
13.9%US$43.18US$25.91n/a16
Oct ’25US$38.35
US$35.65
-7.0%
12.8%US$44.65US$26.79n/a16
Sep ’25US$35.02
US$34.71
-0.9%
13.3%US$43.90US$26.34n/a16
Aug ’25US$33.59
US$34.82
+3.7%
13.5%US$43.31US$25.99n/a16
Jul ’25US$35.48
US$42.54
+19.9%
73.6%US$162.44US$25.99n/a16
Jun ’25US$37.03
US$42.54
+14.9%
73.6%US$162.44US$25.99n/a16
May ’25US$32.98
US$39.87
+20.9%
79.5%US$160.53US$21.40n/a16
Apr ’25n/a
US$38.90
0%
82.4%US$161.12US$21.48n/a16
Mar ’25US$25.10
US$39.13
+55.9%
82.7%US$162.32US$21.64n/a16
Feb ’25US$28.08
US$51.56
+83.7%
82.4%US$163.04US$23.91n/a16
Jan ’25US$29.00
US$81.98
+182.7%
69.5%US$163.52US$23.98n/a15
Dec ’24US$115.23
US$136.52
+18.5%
16.3%US$168.57US$91.35n/a15
Nov ’24n/a
US$134.04
0%
15.5%US$163.78US$88.76US$41.5017
Oct ’24n/a
US$136.49
0%
15.2%US$165.62US$89.75US$38.3517
Sep ’24US$117.11
US$137.42
+17.3%
16.2%US$169.68US$91.95US$35.0217
Aug ’24n/a
US$140.21
0%
16.3%US$173.61US$94.09US$33.5917
Jul ’24n/a
US$135.72
0%
15.9%US$164.10US$91.89US$35.4816
Jun ’24US$111.00
US$131.24
+18.2%
16.0%US$160.93US$90.12US$37.0315
May ’24n/a
US$131.17
0%
16.1%US$161.90US$87.43US$32.9815
Apr ’24n/a
US$131.17
0%
16.1%US$161.90US$87.43n/a15
Mar ’24US$111.65
US$124.20
+11.2%
15.1%US$152.97US$85.45US$25.1015
Feb ’24US$113.58
US$126.01
+10.9%
16.3%US$157.78US$88.14US$28.0815
Jan ’24n/a
US$115.64
0%
16.8%US$149.72US$83.63US$29.0016
Dec ’23US$97.49
US$115.64
+18.6%
16.8%US$149.72US$83.63US$115.2316
Nov ’23n/a
US$108.50
0%
16.8%US$144.49US$70.75n/a17

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Ecora Resources

UK£162.5m

Operates as a natural resource royalty and streaming company in Australia, North and South America, Europe, and internationally.

ECRA.F

UK£0.86

7D

2.0%

1Y

-29.5%

Huntsman

US$3.4b

Manufactures and sells diversified organic chemical products worldwide.

HUN

US$19.43

7D

0.4%

1Y

-20.1%

Chemtrade Logistics Income Fund

CA$1.4b

Offers industrial chemicals and services in Canada, the United States, and South America.

CGIF.F

CA$8.05

7D

-3.0%

1Y

22.0%